Source:http://linkedlifedata.com/resource/pubmed/id/10998524
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2000-10-10
|
pubmed:abstractText |
The ORL1 receptor is a G protein-coupled receptor structurally related to the opioid receptors, whose endogenous ligand is the heptadecapeptide nociceptin/orphanin FQ. In this review, data which have contributed to the mapping of the anatomic distribution of the ORL1 receptor have been collated with an emphasis on their relation to physiological functions. The ORL1 receptor is widely expressed in the central nervous system, in particular in the forebrain (cortical areas, olfactory regions, limbic structures, thalamus), throughout the brainstem (central periaqueductal gray, substantia nigra, several sensory and motor nuclei), and in both the dorsal and ventral horns of the spinal cord. Regions almost devoid of ORL1 receptors are the caudate-putamen and the cerebellum. ORL1 mRNA and binding sites exhibit approximately the same distribution pattern, indicating that the ORL1 receptor is located on local neuronal circuits. The ORL1 receptor is also expressed at the periphery in smooth muscles, peripheral ganglia, and the immune system. The anatomic distribution of ORL1 receptor suggests a broad spectrum of action for the nociceptin/orphanin FQ system (sensory perception, memory process, emotional behavior, etc.).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Ligands,
http://linkedlifedata.com/resource/pubmed/chemical/Opioid Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Opioid,
http://linkedlifedata.com/resource/pubmed/chemical/Vasodilator Agents,
http://linkedlifedata.com/resource/pubmed/chemical/nociceptin,
http://linkedlifedata.com/resource/pubmed/chemical/nociceptin receptor
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0196-9781
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
907-17
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10998524-Animals,
pubmed-meshheading:10998524-Binding Sites,
pubmed-meshheading:10998524-Brain Stem,
pubmed-meshheading:10998524-Humans,
pubmed-meshheading:10998524-Immune System,
pubmed-meshheading:10998524-Ligands,
pubmed-meshheading:10998524-Mice,
pubmed-meshheading:10998524-Models, Biological,
pubmed-meshheading:10998524-Opioid Peptides,
pubmed-meshheading:10998524-RNA, Messenger,
pubmed-meshheading:10998524-Rats,
pubmed-meshheading:10998524-Receptors, Opioid,
pubmed-meshheading:10998524-Spinal Cord,
pubmed-meshheading:10998524-Tissue Distribution,
pubmed-meshheading:10998524-Vasodilator Agents
|
pubmed:year |
2000
|
pubmed:articleTitle |
Tissue distribution of the opioid receptor-like (ORL1) receptor.
|
pubmed:affiliation |
Institut de Pharmacologie et Biologie Structurale, 205 route de Narbonne, 31077, Toulouse, France. manuate@ipbs.fr
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|